hyponatremia

. alongside diuretics and treatment of the underlying condition (e.g., heart failure optimization). Pharmacological Interventions Recent advances have introduced vasopressin receptor antagonists (tolvaptan, conivaptan) as targeted therapies that promote free water excretion without affect